2 terminated. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
| Phase 2 | 1 | Terminated 1 |
Follow Adrucil: new trials by email Literature Review of Adrucil trials Research Report on Adrucil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors bevacizumab, 5-fluorouracil, leucovorin - Gastrointestinal Carcinoid Tumor, Islet Cell Tumor | Phase 2 / Phase 3 | Terminated | University of California, San Francisco | 36 | 2005-06-08 | 2023-05-22 |
| Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed fluorouracil, leucovorin calcium - Colorectal Cancer | Phase 3 | Terminated | ECOG-ACRIN Cancer Research Group | 859 | 1993-10-01 | 2023-06-28 |
Adenoma, Islet Cell (1) · Carcinoma, Islet Cell (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Gastrinoma (1) · Glucagonoma (1) · Insulinoma (1) · Lung Neoplasms (1) · Neoplasms (1) · Neuroendocrine Tumors (1) · Somatostatinoma (1) · Vipoma (1)
ECOG-ACRIN Cancer Research Group (1) · University of California, San Francisco (1)
United States (2)
Emily K. Bergsland, MD (1) · Mary M. Kemeny, MD, FACS (1)
U10CA023318 (1)